The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

hyperbranch.com

Founded Year

2003

Stage

Acquired | Acquired

Total Raised

$17.39M

Valuation

$0000 

About HyperBranch Medical Technology

HyperBranch Medical Technology is a specialty medical device company that develops and markets products primarily for the traumatic or surgically induced wound market. The company's products are capable of adhering tissues, preventing leakage, preventing infection, and promoting healing that results in better clinical outcomes for the patient. The technology on which the products are based is synthetic, safe, and highly configurable to meet varying physical and degradation requirements for a wide range of surgical procedures.

HyperBranch Medical Technology Headquarter Location

804-12 Capitola Drive

Durham, North Carolina, 27713,

United States

919-433-3325

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing HyperBranch Medical Technology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

HyperBranch Medical Technology is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,377 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,900 items

HyperBranch Medical Technology Patents

HyperBranch Medical Technology has filed 12 patents.

The 3 most popular patent topics include:

  • Surgical removal procedures
  • Diseases of the eye and adnexa
  • Eye surgery
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/5/2020

6/8/2021

Diseases of the eye and adnexa, Eye surgery, Ophthalmology, Vision, Surgical removal procedures

Grant

Application Date

6/5/2020

Grant Date

6/8/2021

Title

Related Topics

Diseases of the eye and adnexa, Eye surgery, Ophthalmology, Vision, Surgical removal procedures

Status

Grant

Latest HyperBranch Medical Technology News

October 11, 2018 - H.I.G. BioHealth Partners Completes Sale of HyperBranch Medical Technology, Inc....

Dec 28, 2018

BioHealth Partners (“H.I.G.”), the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global private equity investment firm with over $27 billion of equity capital under management,* recently announced the sale of HyperBranch Medical Technology, Inc. (“HyperBranch”) to Stryker Corporation (NYSE:SYK), one of the world’s leading medical technology companies, for a total equity value of approximately $220 million in an all cash transaction. HyperBranch is dedicated to developing medical devices based on its proprietary polymers and cross-linked hydrogels. Its Adherus AutoSpray Dural Sealant product is one of only two FDA-approved dural sealants on the market. Michael Wasserman, Ph.D., an H.I.G. Managing Director and former HyperBranch board member, said, “Together with HyperBranch’s talented management team and board, we successfully grew the company into a leader in the surgical sealant space, commercializing innovative products with significant benefits to patients, physicians and healthcare providers.” Cooley, LLP represented HyperBranch in the transaction. About H.I.G. BioHealth Partners H.I.G. BioHealth Partners is the dedicated life-science investment affiliate of H.I.G. BioHealth Partners invests in a broad range of healthcare opportunities across sectors and stages, principally in companies developing therapeutic drugs, medical devices, and diagnostics for significant unmet medical needs. With approximately $400 million in committed capital, H.I.G. BioHealth Partners invests $5 million to $40 million per company over the life of an investment. For more information, please refer to the H.I.G. BioHealth Partners website at www.higbio.com . * Based on total capital commitments managed by H.I.G. Capital and affiliates.

  • When was HyperBranch Medical Technology founded?

    HyperBranch Medical Technology was founded in 2003.

  • Where is HyperBranch Medical Technology's headquarters?

    HyperBranch Medical Technology's headquarters is located at 804-12 Capitola Drive, Durham.

  • What is HyperBranch Medical Technology's latest funding round?

    HyperBranch Medical Technology's latest funding round is Acquired.

  • How much did HyperBranch Medical Technology raise?

    HyperBranch Medical Technology raised a total of $17.39M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.